Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
370 articoli
New research reveals combined treatments targeting multiple brain pathways outperform traditional single-drug strategies for Alzheimer's disease.
New research reveals how targeting brain inflammation could unlock novel therapeutic approaches for Alzheimer's disease.
Brain-derived pTau217 blood test shows superior accuracy for detecting Alzheimer's pathology compared to existing tests.
New brain organoid study shows autophagy-boosting compounds can clear harmful tau proteins and rescue synapses in Alzheimer's disease models.
Antibody therapies show promise for preventing Alzheimer's in cognitively healthy people with disease biomarkers.
Recent breakthrough drugs targeting amyloid plaques slow cognitive decline, but combination therapies may unlock better outcomes.
New research reveals that inconsistent sleep timing and quality drive faster accumulation of toxic brain proteins linked to Alzheimer's disease.
Researchers modified astrocytes with chimeric antigen receptors to target amyloid plaques, showing promise for Alzheimer's treatment.
Large study finds genetic background doesn't explain mitochondrial damage in neurodegenerative disease, pointing to complex causes.
Editorial raises concerns about influential 2009 study on Cerebrolysin's effects on brain degeneration in Alzheimer's models.
New research identifies distinct toxic tau protein clusters that drive aggressive Alzheimer's progression, opening doors for personalized treatments.
New research reveals when harmful tau proteins begin accumulating in Down syndrome brains, offering insights into Alzheimer's prevention.
